Cargando…
Nimesulide, a COX-2 inhibitor, sensitizes pancreatic cancer cells to TRAIL-induced apoptosis by promoting DR5 clustering †
Nimesulide is a nonsteroidal anti-inflammatory drug and a COX-2 inhibitor with antitumor and antiproliferative activities that induces apoptosis in oral, esophagus, breast, and pancreatic cancer cells. Despite being removed from the market due to hepatotoxicity, nimesulide is still an important rese...
Autores principales: | Vunnam, Nagamani, Young, Malaney C., Liao, Elly E., Lo, Chih Hung, Huber, Evan, Been, MaryJane, Thomas, David D., Sachs, Jonathan N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9928464/ https://www.ncbi.nlm.nih.gov/pubmed/36775838 http://dx.doi.org/10.1080/15384047.2023.2176692 |
Ejemplares similares
-
Zafirlukast
Is a Promising Scaffold for Selectively
Inhibiting TNFR1 Signaling
por: Vunnam, Nagamani, et al.
Publicado: (2023) -
Fluorescence
Lifetime Measurement of Prefibrillar
Sickle Hemoglobin Oligomers as a Platform for Drug Discovery in Sickle
Cell Disease
por: Vunnam, Nagamani, et al.
Publicado: (2022) -
Following the trail from COX-2 to clotting
por: Bashyam, Hema
Publicado: (2007) -
Targeting KSHV/HHV-8 Latency with COX-2 Selective Inhibitor Nimesulide: A Potential Chemotherapeutic Modality for Primary Effusion Lymphoma
por: George Paul, Arun, et al.
Publicado: (2011) -
Dr. Coxe, on Vaccination
por: Coxe, John Redman
Publicado: (1805)